3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
28
Neoplasms
15
Carcinoma, Non-Small-Cell Lung
7
Multiple Myeloma
6
Hematologic Neoplasms
6
Neoplasm Metastasis
4
Lymphoma
4
Leukemia, Myeloid, Acute
3
Colorectal Neoplasms
3
Brain Neoplasms
3
Biliary Tract Neoplasms
3
Thyroid Neoplasms
2
Thyroid Cancer, Papillary
2
Skin Neoplasms
2
Glioma
2
Cholangiocarcinoma
2
Bile Duct Neoplasms
2
Adenocarcinoma, Follicular
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Oligodendroglioma
1
Nonseminomatous germ cell tumor
1
Neurofibromatosis 1
1
Neurofibroma, Plexiform
1
Neurocytoma
1
Neuroblastoma
1
Myelodysplastic Syndromes
1
Interventions
Epoetin Alfa
7
Darbepoetin alfa
6
epoetin beta
4
Lenalidomide
4
Cyclophosphamide
4
ACE-011
4
fludarabine
3
Busulfan
3
thymoglobulin
2
telapristone acetate
2
luspatercept
2
fludarabine phosphate
2
Cyclosporine
2
Antilymphocyte Serum
2
AP 1903 reagent
2
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
2
vactosertib
1
ruxolitinib
1
roxadustat
1
obinutuzumab
1
ibrutinib
1
fosphenytoin
1
ferrous sulfate
1
ferric gluconate
1
ferric carboxymaltose
1
eltrombopag
1
angiotensin I (1-7)
1
Whole-Body Irradiation
1
Thiotepa
1
Therapeutics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Anemia
×
trametinib
×
Clear all
No trials found.